appConfigEntityId

bodyType

customContents

entityId

entityUuid

isVideo

articlePageQuery

article

articleSchemaContent

content

hooksArticlePageAdvertisementConfigArticle

hooksArticlePageFloatingButtonConfigArticle

appConfig

filter

json

liveArticle

William Langley

Pfizer’s Covid-19 vaccine is as effective against new strains of the virus raging in Britain and South Africa as it is against previously detected ones, according to new research.
Pfizer released the results of a joint study conducted with the University of Texas Medical Branch on Thursday.
It tested the vaccine resistance of 20 participants in its earlier trials against lab-made versions of the new strains of the virus. It found no reduction in their ability to neutralise the new strains.
Both strains, which appear more contagious than previous ones, are rampant in the countries in which they were first detected. Britain recorded a record 62,322 cases of Covid-19 on Wednesday, with South Africa recording over 21,000.


Countries around the world have issued travel bans and restrictions to prevent the transmission of the new strains across borders, but both have already spread globally.
Whilst there is no evidence that they cause a more severe illness, the heightened contagiousness of the strains has raised concerns. Scientists also fear that the strain discovered in South Africa carries a mutation that may make it more resistant to vaccines.
Governments worldwide have been pinning their hopes for a return to normal life – and economic recovery – on the success of vaccine roll-outs.
The Pfizer vaccine, developed in the US, was one of the first to pass phase 3 trials after it reported an efficacy rate of 95 per cent. In December, Britain became the first country to officially begin rolling it out.
Professor Leo Poon Lit-man, from the University of Hong Kong’s School of Public Health, said that although the new research was only a preliminary study with a small sample size of 20, it was an impressive turnaround for the Pfizer team.


“The sample size is small but that is the reality, not many people have been vaccinated,” he said.
Poon said that, despite the small sample size of the current study, the Pfizer vaccine had been trialled in different countries around the world, meaning it likely had “some reasonable level of protection”, regardless of region.
The study noted that it used lab-made versions of the new strains which did not perfectly mimic the full set of mutations found on the new strains, limiting its findings.
Sinovac Biotech Covid-19 vaccine seen as 78 per cent effective in Brazil
“The most important question is, do these serum samples neutralise the natural strains [of the virus]?” Poon said. “If that can be shown, it will be even more convincing.”
On Thursday, Mike Ryan, the World Health Organization’s executive director for the health emergencies programme, said that work was ongoing to find out whether vaccines would still be effective, but that so far the evidence looked promising.
“Right now as far as we can see, the data is pointing to these vaccines still being effective, and we’re not overly concerned that that is going to change,” he said.


Hong Kong’s Peninsula Hotels sees ‘bleisure’ boom after pandemic curbs, CEO says

US could require US$15,000 bonds for some tourist, business visas

China’s Shenzhen, Guangzhou airports hit record highs, surpass pre-Covid passenger levels

Landmark US Chinatown survived Covid, anti-Asian violence – but tariffs pose new threat

Coronavirus pandemic

Coronavirus: Pfizer raises hopes vaccine can fight new strains found in Britain and South Africa

The Pfizer vaccine reported an 95 per cent efficacy rate. Photo: EPA-EFE

Pfizer-BioNTech vaccine effective against mutation in new coronavirus strains, study finds

A man receives the Pfizer-BioNTech Covid-19 vaccine on Friday in St Albans, Britain. Photo: Reuters

Iran bans coronavirus vaccines from US, Britain

An Iranian woman is injected with a locally made Covid-19 vaccine in Tehran. Photo: AP

Iranian Supreme Leader Ayatollah Ali Khamenei. Photo: DPA

Coronavirus: a Sinovac Biotech vaccine is seen as 78 per cent effective in Brazil

Butantan Institute director Dimas Covas at a news briefing in Sao Paulo, Brazil, on Thursday. The institute said it had requested emergency use approval for CoronaVac from the national health agency, Anvisa. Photo: AFP

Brazil's Sao Paulo state governor Joao Doria holds a box of China's Sinovac coronavirus disease (COVID-19) vaccine during a news conference about its efficacy results at Instituto Butantan in Sao Paulo, Brazil January 7, 2021. REUTERS/Amanda Perobelli

Coronavirus: Britain breaks single-day infection record as mutant strain spreads

An ambulance rushes to a patient in Romford, UK, on Saturday. Photo: Reuters

Coronavirus: South Africa strain ‘more of a problem’ than UK variant, says British health secretary

South African paramedics assess a Covid-19 patient in Lenasia, Johannesburg, on Monday. Photo: AFP

A video grab from footage broadcast by the UK Parliament's Parliamentary Recording Unit (PRU) shows Britain's Health Secretary Matt Hancock as he gives a statement to the House of Commons in London on December 30, 2020, on the state of covid-19 vaccinations and new restriction areas in England. - Britain on Wednesday became the first country in the world to approve AstraZeneca and Oxford University's low-cost Covid vaccine, raising hopes it will help tackle surging cases and ease pressure on creaking health services. (Photo by - / PRU / AFP) / RESTRICTED TO EDITORIAL USE - NO USE FOR ENTERTAINMENT, SATIRICAL, ADVERTISING PURPOSES - MANDATORY CREDIT " AFP PHOTO / PRU "

A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen at Hamilton Park Nursing and Rehabilitation, a nursing home facility in Brooklyn, New York, U.S., January 4, 2021. REUTERS/Yuki Iwamura

News

China

Science

Coronavirus

Health & Medicine

Europe


Preliminary research conducted with the University of Texas suggests it will still work against the new variants of Covid-19
The viral mutations have proved more transmissible than other strains as infection rates soar in some countries



Preliminary research conducted with the University of Texas suggests it will still work against the new variants of Covid-19.
